Turtle Creek Wealth Advisors »

Biogen Idec shares owned by Turtle Creek Wealth Advisors

Quarter-by-quarter ownership of Biogen Idec (BIIB) shares owned by Turtle Creek Wealth Advisors from 13F filings

Historical chart of Turtle Creek Wealth Advisors investment in Biogen Idec

Tip: Access up to 7 years of quarterly data

All positions including Biogen Idec held by Turtle Creek Wealth Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Biogen Idec by Turtle Creek Wealth Advisors

Quarter filed Position value Share count Share price at filing
2025-12-31 $257k 1.5k 175.99
2023-12-31 $19k 73 258.77

More positions owned by Turtle Creek Wealth Advisors

Vanguard Index Fds S&p 500 Etf Shs (VOO)
Apple (AAPL)
Ishares Tr Core Msci Eafe (IEFA)
NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Eli Lilly & Co. (LLY)
Alphabet Cap Stk Cl A (GOOGL)
Amazon (AMZN)
JPMorgan Chase & Co. (JPM)
Broadcom (AVGO)
Meta Platforms Cl A (META)
Caterpillar (CAT)
Ishares Tr Core S&p Mcp Etf (IJH)
Alphabet Cap Stk Cl C (GOOG)
Blackrock (BLK)

View all positions for Turtle Creek Wealth Advisors

Top funds holding Biogen Idec

Vanguard Group
BlackRock
PRIMECAP Management Company
State Street Corporation
Wellington Management Company
Geode Capital Management
Point72 Asset Management
Norges Bank Investment Management
Susquehanna International
AQR Capital Management
Robeco Investment Management
Invesco
Barclays
Legal & General Group
Millennium Management

View all funds holding Biogen Idec